Davenport Andrew
UCL Center for Nephrology, Royal Free and University College Medical School, London, UK.
Nephron Clin Pract. 2009;113(1):c33-7. doi: 10.1159/000228073. Epub 2009 Jul 10.
Cardiovascular morbidity and mortality is increased in diabetic haemodialysis patients. Diabetic subjects may suffer greater thirst and thereby be predisposed to increased interdialytic weight gains and hypertension.
175 established adult diabetic haemodialysis patients attending outpatient haemodialysis thrice weekly were audited during a 1-week interval.
Despite fewer patients prescribed antihypertensive medications (46%), the mean pre-dialysis systolic blood pressure was lowest in those patients with the lowest HbA1c values (<or=6%; 146 +/- 27 mm Hg), versus 154 +/- 25 mm Hg for the highest group, with a HbA1c of >8%, of whom 70% were prescribed antihypertensive medications (p < 0.05). Both absolute and percentage interdialytic weight gain was lowest in the group with the best diabetic control: 2.0 +/- 1 kg and 2.76 +/- 1.5% versus 2.5 +/- 1.1 kg and 3.3 +/- 1.3%, respectively (p < 0.05).
Poor diabetic control may increase thirst and salt intake, leading to increased interdialytic weight gains, associated with systolic hypertension, and as such, diabetic control is an important facet in the management of the diabetic haemodialysis patient.
糖尿病血液透析患者的心血管发病率和死亡率会升高。糖尿病患者可能会更易口渴,进而倾向于增加透析间期体重增长及高血压风险。
对175例成年糖尿病血液透析患者进行了为期1周的审核,这些患者每周三次到门诊进行血液透析。
尽管服用抗高血压药物的患者较少(46%),但糖化血红蛋白(HbA1c)值最低(≤6%)的患者,其透析前平均收缩压最低(146±27mmHg),而HbA1c>8%的最高组患者为154±25mmHg,其中70%的患者服用抗高血压药物(p<0.05)。糖尿病控制最佳组的透析间期绝对体重增加和体重增加百分比均最低:分别为2.0±1kg和2.76±1.5%,而其他组分别为2.5±1.1kg和3.3±1.3%(p<0.05)。
糖尿病控制不佳可能会增加口渴感和盐摄入量,导致透析间期体重增加,进而引发收缩期高血压,因此,糖尿病控制是糖尿病血液透析患者管理中的一个重要方面。